Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-08T03:59:37.811Z Has data issue: false hasContentIssue false

Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor

Published online by Cambridge University Press:  24 April 2014

J. SAVAGE
Affiliation:
Parasite Therapeutics Research Group, School of Biological Sciences, Medical Biology Centre, The Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland
M. MEANEY
Affiliation:
Parasite Therapeutics Research Group, School of Biological Sciences, Medical Biology Centre, The Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland
G. P. BRENNAN
Affiliation:
Parasite Therapeutics Research Group, School of Biological Sciences, Medical Biology Centre, The Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland
E. HOEY
Affiliation:
Parasite Therapeutics Research Group, School of Biological Sciences, Medical Biology Centre, The Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland
A. TRUDGETT
Affiliation:
Parasite Therapeutics Research Group, School of Biological Sciences, Medical Biology Centre, The Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland
I. FAIRWEATHER*
Affiliation:
Parasite Therapeutics Research Group, School of Biological Sciences, Medical Biology Centre, The Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland
*
* Corresponding author: School of Biological Sciences, Medical Biology Centre, The Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland. E-mail: i.fairweather@qub.ac.uk
Rights & Permissions [Opens in a new window]

Summary

A study has been carried out to investigate whether the action of triclabendazole (TCBZ) against Fasciola hepatica is altered by inhibition of P-glycoprotein (Pgp)-linked drug efflux pumps. The Sligo TCBZ-resistant fluke isolate was used for these experiments and the Pgp inhibitor selected was R(+)-verapamil [R(+)-VPL]. In the first experiment, flukes were initially incubated for 2 h in R(+)-VPL (100 μ m), then incubated in R(+)-VPL+triclabendazole sulphoxide (TCBZ.SO) (50 μg mL−1, or 133·1 μ m) until flukes ceased movement (at 9 h post-treatment). In a second experiment, flukes were incubated in TCBZ.SO alone and removed from the incubation medium following cessation of motility (after 15 h). In the third experiment, flukes were incubated for 24 h in R(+)-VPL on its own. Changes to the testis tubules and vitelline follicles following drug treatment and following Pgp inhibition were assessed by means of light microscope histology and transmission electron microscopy. Incubation of the Sligo isolate in either R(+)-VPL or TCBZ.SO on their own had a limited impact on the morphology of the two tissues. Greater disruption was observed when the drugs were combined, in terms of the block in development of the spermatogenic and vitelline cells and the apoptotic breakdown of the remaining cells. Sperm formation was severely affected and abnormal. Large spaces appeared in the vitelline follicles and synthesis of shell protein was disrupted. The results of this study support the concept of altered drug efflux in TCBZ-resistant flukes and indicate that drug transporters may play a role in the development of drug resistance.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2014 
Figure 0

Fig. 1. Light micrographs of Fasciola hepatica (Sligo isolate) showing profiles of testis tubules of an untreated specimen (A); a fluke following in vitro treatment for 24 h with R(+)-verapamil (100 μm) (B); flukes following incubation in vitro for 15 h in TCBZ.SO (50 μg mL−1) (C and D); and specimens treated in vitro with a combination of R(+)-verapamil (100 μm)+TCBZ.SO (50 μg mL−1) until inactivity at 9 h (E and F). (A) Control fluke image. Primary (1°SG) and secondary (2°SG) spermatogonia are located at the periphery of the testis tubule, and numerous tertiary (3°SG) spermatogonia are present. Few primary (1°SC) spermatocytes are evident. Spermatids (ST) are numerous, with evidence of nuclear elongation (arrows). SP, mature spermatozoa. (B) R(+)-verapamil-treated fluke. Testis tubule showing peripherally located primary (1°SG) and secondary (2°SG) spermatogonia, also tertiary (3°SG) spermatogonia. Spermatid clusters (ST) are present and spermatids at various stages of maturation and showing elongation of the nuclei (arrows) can also be seen. 1°SC, primary spermatocytes; SP, mature spermatozoa. (C) TCBZ.SO-treated fluke. Primary (1°SG) and secondary (2°SG) spermatogonia are located at the periphery of the tubule. Primary (1°SC) and secondary (2°SC) spermatocytes are more centrally located. Mature spermatozoa (SP) are present in close parallel bundles throughout the tubule. 3°SG, tertiary spermatogonia. (D) TCBZ.SO-treated fluke. Primary (1°SG) and secondary (2°SG) spermatogonia are present in close proximity to the peripheral wall. Tertiary spermatogonia (3°SG) are numerous and located in the central tubule region. Mature spermatozoa (SP) are also numerous and are located throughout the tubule. 1°SC, primary spermatocytes; 2°SC, secondary spermatocytes. (E) Combination-treated fluke. Few primary (1°SG) and secondary (2°SG) spermatogonia are visible along the tubule wall (arrow) and only a small number of tertiary spermatogonia (3°SG) can be seen. Large apoptotic-like bodies can be seen in the tubule (arrowheads). No mature spermatozoa were visible in the tubule. 1°SC, primary spermatocytes; 2°SC, secondary spermatocytes. (F) Combination-treated fluke. Few primary (1°SG) and secondary (2°SG) spermatogonia are visible along the tubule wall (arrow). Tertiary (3°SG) spermatogonia are present in the central region of the tubule. Primary (1°SC) and secondary (2°SC) spermatocytes are present, but no mature spermatozoa or spermatids are visible. Large apoptotic-like bodies are present in the tubule (arrowheads).

Figure 1

Fig. 2. Transmission electron micrographs (TEMs) showing profiles of testis tubules of Fasciola hepatica (Sligo isolate) following in vitro treatment for 24 h with R(+)-verapamil (100 μm). (A) A TEM showing a group of spermatogonia (1°/2°SG) in close proximity to the wall (arrowed) of the testis tubule. N, nucleus. (B) A TEM of a group of primary spermatocytes (1°SC), which are joined together by the central cytophore (cp). N, nucleus. (C) TEM of the nucleus of an individual primary spermatocyte (1°SC) containing a visible synaptonemal complex (arrow). Inset shows a high magnification image of the synaptonemal complex, which consists of two homologous chromosomes separated by a medial complex (mc) and with heterochromatin (arrows) visible on either side of the complex. (D) A TEM showing a cluster of secondary spermatocyte (2°SC) cells, with cytoplasmic bridges (arrows) connecting the cells. Pw, peripheral wall of the tubule; N, nucleus. (E) A TEM of a spermatid cell showing the elongation of the nucleus (N), and the chromatin within the nucleus which is organized into lamellar-like sheets (arrow). Basal bodies (bb), a central body (cb) and mitochondria (m) are also evident. A single row of peripheral microtubules lies beneath the plasma membrane (PM). (F) A TEM of a cross-section of six axonemes (ax), each possessing 9 sets of outer doublet microtubules (mt) arranged around a central element. Dynein side-arms (d) are visible on the outer microtubules, and radial spokes (rs) connect the microtubules to the central element.

Figure 2

Fig. 3. Transmission electron micrographs (TEMs) showing profiles of testis tubules of Fasciola hepatica (Sligo isolate) following in vitro treatment with TCBZ.SO (50 μg mL−1) until inactivity at 15 h. (A) TEM of a group of secondary spermatogonia (2°SG) located near to the wall (arrow) of the testis tubule, showing the typically high nucleocytoplasmic ratio. N, nucleus. (B) TEM showing a group of primary spermatocytes (1°SC). Mitochondria (m) are present in the cytoplasm of the cells at the edge of the cell cluster and appear to be normal. (C) TEM showing a cluster of secondary spermatocyte (2°SC) cells, with numerous cytoplasmic bridges (arrows) connecting them. N, nucleus. (D) TEM showing a section through a rosette of spermatid (ST) cells. Elongated nuclei (N) are visible and elongation of individual spermatid cells has occurred. Mature spermatozoa (SP) are visible at the edge of the spermatid rosette. The mitochondria (m) appear normal. (E) TEM showing transverse sections of mature spermatozoa (SP), containing nuclei (N), axonemes (ax) and cortical microtubules (arrow). Free axonemes are also visible in the lumen of the tubule. (F) TEM showing transverse sections of mature spermatozoa (SP). Axonemes (ax) and cortical microtubules (arrows) are visible within the spermatozoa. The mitochondria (m) in the spermatozoa appear to be disrupted and no nuclei are visible.

Figure 3

Fig. 4. Transmission electron micrographs (TEMs) showing profiles of testis tubules of Fasciola hepatica (Sligo isolate) following in vitro treatment with a combination of R(+)-verapamil (100 μm)+TCBZ.SO (50 μg mL−1) until inactivity at 9 h. (A) TEM showing a cross-section of two primary spermatogonial (1°SG) cells in close proximity to the peripheral wall (pw) of the testis tubule. Disruption to the nucleus (N) is evident, with loss of definition of the nuclear membrane (nm). The cell membrane has ruptured (arrow) and the cytoplasm is electron-lucent in this region. (B) TEM showing a cluster of primary spermatocytes (1°SC) containing irregular nuclei (N) with dense chromatin. The cell membrane appears to have ruptured (black arrow) in one region, and large electron-lucent areas (white arrows) are present within the cytoplasm. The mitochondria (m) appear rounded and swollen. Cp, cytophore. (C) TEM of a cross-section of an abnormal cluster of spermatid (ST) cells. The chromatin within the nucleus (N) appears to be loosely arranged into lamellar-like sheets, but elongation of the nucleus is not evident. The plasma membrane (pm) appears thickened and invaginated to form a groove-like collar (arrow). The zone of differentiation of a spermatid cell is visible, with one axoneme (ax) extending away from its basal body (bb); the two basal bodies are situated on either side of the central body (cb). (D) TEM showing a cross-section through the median process (mp) and axonemes (ax) which are separate from one another. The median process (mp) is lined with cortical microtubules (arrows). The centre of the median process appears to be very electron-lucent. A large number of free axonemes is present in close proximity to the median processes. (E) TEM showing a cluster of spermatozoa in various abnormal states. Multi-axonemal spermatozoa (arrows) are present, some of which contain disrupted, electron-lucent mitochondria (m). Multiple free axonemes (ax) are also visible. Other spermatozoa (SP) contain a nucleus (N) which is irregular in shape and its content is abnormally granular. (F) A cross-section of a mature spermatozoon (SP) which appears to be extremely swollen and contains an abnormally large electron-lucent mitochondrion (m). A multi-axonemal spermatozoon (arrow) is also present. Inset shows a high-power micrograph of an individual axoneme, which possesses the normal 9+1 arrangement of microtubules. N, nucleus.

Figure 4

Fig. 5. Transmission electron micrographs (TEMs) showing the vitelline follicles of Fasciola hepatica (Sligo isolate) following in vitro treatment with R(+)-verapamil (100 μm) for 24 h (A and B), and TCBZ.SO (50 μg mL−1) until inactivity at 15 h (C-F). (A) R(+)-verapamil-treated fluke. A low-power TEM of a vitelline follicle containing mature vitelline cells (M) and an intermediate type 1 cell (It1). Shell globule clusters (sgc), glycogen (g) and yolk globules (y) are present in the mature cells, and eggshell globule clusters are present in the It1 cell. N, nucleus. (B) R(+)-verapamil-treated fluke. A TEM showing a vitelline follicle containing all stages of cell development. A mature cell (M) and a number of intermediate type 1 (It1) and type 2 (It2) vitelline cells are present, along with a stem cell (S) and a nurse cell (NC). Shell globule clusters (sgc), glycogen granules (g), a nucleus (N) and yolk globules (y) are all visible in the mature cell. Shell globule clusters are also present in the It1 and It2 cells. (C) TCBZ.SO-treated fluke. A TEM showing intermediate type 2 (It2) vitelline cells containing large single shell protein globules (spg) and small shell globule clusters (sgc). Swelling (arrows) of the cisternae of granular endoplasmic reticulum is evident in the It2 cells. S, stem cell. (D) TCBZ.SO-treated fluke. A high-power TEM showing swelling of the cisternae of granular endoplasmic reticulum (ger) in a mature vitelline cell. A shell globule cluster (sgc) is present, as are glycogen granules (g) and yolk globules (y). N, nucleus. (E) TCBZ.SO-treated fluke. A TEM of a vitelline follicle containing mature cells (M) at the centre of the follicle, and intermediate type 1 (It1) and type 2 (It2) cells and a stem cell (S) at the periphery of the follicle. Large shell protein globules (black arrows) and small shell globule clusters (white arrows) are present in mature and It2 cells, while only small, single shell protein globules (arrowheads) are present in It1 cells. (F) TCBZ.SO-treated fluke. A low-power TEM showing an abnormal distribution of cells within a vitelline follicle. A nurse cell (NC) and It1 (It1) cells are situated in the centre of the follicle, whilst It2 (It2) and mature (M) cells are situated at the periphery. S, stem cell.

Figure 5

Fig. 6. Transmission electron micrographs (TEMs) showing the vitelline follicles of Fasciola hepatica (Sligo isolate) following in vitro treatment with a combination of R(+)-verapamil (100 μm)+TCBZ.SO (50 μg mL−1) until inactivity at 9 h. (A) TEM showing separation of the vitelline cells from the nurse cell processes (black arrows) which has resulted in large open spaces (arrowheads) within the follicle. Intermediate type 1 (It1) cells appear rounded and swelling of the cisternae of granular endoplasmic reticulum (white arrows) is evident within the It2 (It2) cell. Yolk globules (y) and shell protein globules (spg) are present within the mature cell (M). (B) A TEM showing separation of the vitelline cells from the nurse cell processes (black arrows) which has resulted in large open spaces (arrowheads) between the vitelline cells. Swelling of the cisternae of granular endoplasmic reticulum (white arrows) is visible in an intermediate type 2 (It2) cell. Large shell protein globules (spg) and shell globule clusters (sgc) are present in the mature (M) and It2 cells. It1, intermediate type 1 cell; S, stem cell; y, yolk globules. (C) TEM showing breakdown of the cytoplasm (black arrows) within a mature vitelline cell (M). Shell protein globules (spg), shell globule clusters (sgc) and yolk globules (y) remain intact. Slight swelling of the cisternae of the granular endoplasmic reticulum (white arrows) can be seen in intermediate type 2 (It2) cells. (D) A high-power TEM showing discrete differences in disruption within intermediate-type vitelline cells. There is extreme swelling of the cisternae of granular endoplasmic reticulum (arrows) in the It2 (It2) cell, whilst the granular endoplasmic reticulum appears normal in the adjacent It1 (It1) cell. N, nucleus.